Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems

Published:2021-03-01 Issue:7 Volume:116 Page:1465-1475
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Wong Robert J.,Jain Mamta K.,Therapondos George,Niu Bolin,Kshirsagar Onkar,Thamer Mae

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study;Polaris Observatory;Lancet Gastroenterol Hepatol,2018

2. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin;Kowdley;Hepatology,2012

3. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B;Chang;Hepatology,2010

4. Thirty-year outcomes of the national hepatitis B immunization program in Taiwan;Chiang;JAMA,2013

5. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: A Korean nationwide cohort study;Choi;JAMA Oncol,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Baseline Hepatitis B Virus DNA and On-Treatment Risk of Cirrhosis and Hepatocellular Carcinoma;Gastroenterology Research;2024-06

2. Racial–ethnic differences in liver transplant waitlist outcomes in patients with hepatocellular carcinoma before and after recent changes to allocation policy;Clinical Transplantation;2024-05-28

3. The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis;Heliyon;2024-04

4. Care for Vulnerable Populations with Chronic Liver Disease: A Safety-Net Perspective;Healthcare;2023-10-13

5. On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis B;JHEP Reports;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3